4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological MalignanciesDisease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasmNot yet recruitingPhase 12026-04-16NCT07532746
KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical TrialEBV-associated Haematologic NeoplasmsEnrolling by invitationPhase 12026-04-08NCT05635591
KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical TrialHead and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic diseaseNot yet recruitingEarly phase 12024-12-30NCT06752473
KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical TrialHead and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic diseaseNot yet recruitingEarly phase 12024-05-02NCT06370026